Advertisement
Logos iRiS
Logos iRiS

How the Pediatric Laws Work

The Pediatric Research Equity Act (PREA) of 2003 requires that companies developing new drugs that could be used to treat a condition in children perform clinical trials in kids before winning FDA approval. 

By | March 1, 2012

Infographic: How the Laws Work
View full size JPG | PDF
MATT COLLINS (BABY); US GOVERNMENT ACCOUNTABILITY OFFICE REPORT, "PEDIATRIC RESEARCH," MAY 2011

The Pediatric Research Equity Act (PREA) of 2003 requires that companies developing new drugs that could be used to treat a condition in children perform clinical trials in kids before winning FDA approval. The Best Pharmaceuticals for Children Act (BPCA) of 2002 offers financial incentives for companies to test drugs, either pre- or post-approval, in pediatric trials deemed necessary by the FDA.

Read the full story.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement
QIAGEN ingenuity
QIAGEN ingenuity

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Immune Defect Detected in Knockout Mice
  4. Exploring Emotional Contagion
Advertisement
LabX
LabX
Advertisement
Biosearch Technologies
illumina Corporate
illumina Corporate